NICE goes ahead with controversial drug affordability test


Today the National Institute for Health and Care Excellence has confirmed it will go ahead next month with controversial plans to assess new treatments based on affordability.

You need to be an HSJ subscriber to read more


Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to
  • The HSJ app

Enquire about multi-user access